Résultats de la recherche - 5 results
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
Therapy COVID-19 Female Global Burden of Disease Hospitalization Humans Immunization, Passive Male mortality Respiration, Artificial SAFETY SARS-CoV-2 Standard of Care Treatment Outcome Abstract: ...
Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
Issue 4 Suppl, p.913-22 (2012) Keywords: Animals Antibodies, Viral Antigens, Viral Chickens Gastrointestinal Tract Immunity, Maternally-Acquired Immunization, Secondary Immunoglobulins Influenza A Virus, ...
Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.
Xavier Source: J Gen Virol, Volume 92, Issue Pt 2, p.301-6 (2011) Keywords: Amino Acid Sequence Animals Antibodies, Viral Cell Line Dogs Gene Expression Regulation, Viral Hemocyanin Immune Sera Influenza ...
Production of bovine herpesvirus type 1-seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves.
p.4233-8 (2000) Keywords: Animals Antibodies, Viral Carrier State Cattle Cattle Diseases Herpesviridae Infections Herpesvirus 1, Bovine Immunity, Maternally-Acquired Immunization, Passive Interferon-gamma ...
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data.
der Schoot; Heli Harvala Source: Euro Surveill, Volume 26, Issue 27 (2021) Keywords: Antibodies, Neutralizing Antibodies, Viral COVID-19 Europe Humans Immunization, Passive SARS-CoV-2 Abstract: We ...